Expansion of Tregs, independent of Ag, to effectively prevent and reverse T1D in the NOD mouse, and IL-10 and TGF-β are critical for protection in Treg-mediated therapies30,31. The gene discussed is TGFB1; the disease is type 1 diabetes mellitus.